Molecular and structural insights into the 5‐HT2C receptor as a therapeutic target for substance use disorders
British Journal of Pharmacology September 8, 2023 Maleesha Ubhayarathna, Christopher J. Langmead, Natalie Diepenhorst et al. 10 citations
Abstract Substance use disorder (SUD) is a chronic condition, with maintained abuse of a substance leading to physiological and psychological alterations and often changes in cognitive and social behaviours. Current therapies include psychotherapy coupled with medication; however, high relapse rates reveal the shortcomings of these therapies. The signalling, expression profile, and neurological...